NCT05030285

Brief Summary

This project will pilot a tailored Cognitive Behavioral Therapy (CBT) intervention delivered via telehealth videoconferencing (Tele-CBT) to reduce anxiety in people living with cognitive impairment. A process evaluation will inform its feasibility and implementation in the community nation-wide.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 26, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 1, 2021

Completed
20 days until next milestone

Study Start

First participant enrolled

September 21, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 16, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 16, 2022

Completed
Last Updated

July 24, 2025

Status Verified

July 1, 2025

Enrollment Period

10 months

First QC Date

August 26, 2021

Last Update Submit

July 21, 2025

Conditions

Keywords

PsychotherapyCognitive ImpairmentsAnxiety

Outcome Measures

Primary Outcomes (1)

  • Change in anxiety

    Change from baseline in anxiety as measured by the Rating Anxiety in Dementia Scale (RAID).

    Post assessment (week 8). Scores ranging between 0 to 54 (lower score indicates better outcomes)

Secondary Outcomes (3)

  • Change in depression

    Post assessment (week 8). Scores ranging between 0 to 15 (lower score indicates better outcomes)

  • Change in quality of life

    Post assessment (week 8). Scores ranging between 0 to 52 (higher score indicates better outcomes)

  • Change in carer burden

    Post assessment (week 8). Scores ranging between 0-88 (lower score indicates better outcomes)

Study Arms (2)

Intervention

EXPERIMENTAL

People who are randomised into the intervention arm will undergo 6 weekly psychotherapy sessions

Behavioral: Cognitive Behavioral Therapy (CBT)

Control

NO INTERVENTION

People who are randomised into the control arm will undergo usual care

Interventions

The CBT intervention includes 6 sessions via video-conferencing that has been tailored for people living with cognitive impairment. The sessions incorporate the use of psychoeducation and relaxation videos to improve home-based practise for long-term outcomes.

Intervention

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Persons with a diagnosis of mild cognitive impairment (MCI) or dementia of any aetiology based on a previous diagnosis by a clinician or scoring above threshold (≤32; MCI ≤32 and dementia ≤27) for cognitive impairment in the Modified Telephone Interview for Cognitive Impairment (TICS-M).
  • Persons screening positive for anxiety (scoring ≥9 in the Geriatric Anxiety Inventory, GAI) or reports subjective complaints of anxiety

You may not qualify if:

  • Persons with severe dementia
  • Persons who are unable to communicate or complete questionnaires
  • Persons who are at high risk of suicide as identified by by the University of Queensland Suicidal Risk Assessment administered at the UQ Psychology clinic which has been modified for use by the Dementia and Neuro Mental Health Research Unit
  • Persons who have major depression as the primary complaint without reported symptoms of anxiety.
  • Persons on existing anxiolytics or antidepressants who have not been on a stable dose for at least 12 weeks before starting the trial and are unable to maintain the same dose for the duration of the trial. Changes to medication will be checked at each therapy and assessment session.
  • Persons who are undergoing psychological therapy or will undergo psychological therapy over the trial duration.
  • Entry into the study:
  • Study entry will be determined by discussions with the core investigator team consisting of clinicians and experienced researchers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Queensland

Brisbane, Queensland, 4072, Australia

Location

Related Publications (6)

  • Kuring JK, Mathias JL, Ward L. Prevalence of Depression, Anxiety and PTSD in People with Dementia: a Systematic Review and Meta-Analysis. Neuropsychol Rev. 2018 Dec;28(4):393-416. doi: 10.1007/s11065-018-9396-2. Epub 2018 Dec 7.

    PMID: 30536144BACKGROUND
  • Banks SJ, Raman R, He F, Salmon DP, Ferris S, Aisen P, Cummings J. The Alzheimer's disease cooperative study prevention instrument project: longitudinal outcome of behavioral measures as predictors of cognitive decline. Dement Geriatr Cogn Dis Extra. 2014 Dec 18;4(3):509-16. doi: 10.1159/000357775. eCollection 2014 Sep-Dec.

    PMID: 25685141BACKGROUND
  • Ferretti L, McCurry SM, Logsdon R, Gibbons L, Teri L. Anxiety and Alzheimer's disease. J Geriatr Psychiatry Neurol. 2001 Spring;14(1):52-8. doi: 10.1177/089198870101400111.

    PMID: 11281317BACKGROUND
  • Seyfried LS, Kales HC, Ignacio RV, Conwell Y, Valenstein M. Predictors of suicide in patients with dementia. Alzheimers Dement. 2011 Nov;7(6):567-73. doi: 10.1016/j.jalz.2011.01.006.

    PMID: 22055973BACKGROUND
  • Poon E. A Systematic Review and Meta-Analysis of Dyadic Psychological Interventions for BPSD, Quality of Life and/or Caregiver Burden in Dementia or MCI. Clin Gerontol. 2022 Jul-Sep;45(4):777-797. doi: 10.1080/07317115.2019.1694117. Epub 2019 Nov 22.

    PMID: 31752633BACKGROUND
  • Konnopka A, Konig H. Economic Burden of Anxiety Disorders: A Systematic Review and Meta-Analysis. Pharmacoeconomics. 2020 Jan;38(1):25-37. doi: 10.1007/s40273-019-00849-7.

    PMID: 31646432BACKGROUND

MeSH Terms

Conditions

Cognitive DysfunctionAnxiety Disorders

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Nadeeka Dissanayaka, PhD

    The University of Queensland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Assessors will be blinded to what arm the participant is allocated to.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomised (1:1 ratio) to either the Tele-CBT intervention or usual care (Control) arm.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2021

First Posted

September 1, 2021

Study Start

September 21, 2021

Primary Completion

July 16, 2022

Study Completion

July 16, 2022

Last Updated

July 24, 2025

Record last verified: 2025-07

Locations